Use of PROTACS as molecular probes of angiogenesis
- PMID: 15876533
- PMCID: PMC3226786
- DOI: 10.1016/j.bmcl.2005.04.008
Use of PROTACS as molecular probes of angiogenesis
Abstract
Small molecules designed to specifically activate or inactivate protein functions have been useful to study biological processes. PROTACS are small molecule chimera which comprise a ligand and a peptide recognition motif for an E3 ligase. These novel reagents exploit the ubiquitin-mediated proteasome degradation pathway to target the ligand-bound protein for intracellular degradation. Here, we report that an estrogen receptor (ER)-targeting PROTACS that causes degradation of ER is able to potently inhibit endothelial cell differentiation in a three-dimensional angiogenic sprouting assay. These findings support the use of ER-targeting PROTACS as probes of angiogenesis.
Figures
References
-
- Sakamoto KM, Kim KB, Verma R, Ransick A, Stein B, Crews CM, Deshaies RJ. Mol. Cell. Proteomics. 2003;2:1350. - PubMed
-
- Crews CM, Splittgerber U. Trends Biochem. Sci. 1999;24:317. - PubMed
-
- Schreiber SL. Bioorg. Med. Chem. 1998;6:1127. - PubMed
-
- Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ. Nature. 1999;399:271. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
